Prudential Financial Inc. Sells 73,700 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Prudential Financial Inc. lessened its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 40.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,072 shares of the company's stock after selling 73,700 shares during the quarter. Prudential Financial Inc. owned approximately 0.08% of AdaptHealth worth $1,019,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Assetmark Inc. acquired a new stake in shares of AdaptHealth during the fourth quarter worth approximately $28,000. Blue Trust Inc. boosted its stake in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after buying an additional 1,115 shares during the period. Quarry LP boosted its stake in shares of AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company's stock valued at $67,000 after buying an additional 5,838 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after acquiring an additional 1,690 shares in the last quarter. Finally, LRI Investments LLC increased its stake in shares of AdaptHealth by 32.0% in the third quarter. LRI Investments LLC now owns 15,331 shares of the company's stock worth $172,000 after acquiring an additional 3,713 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Stock Performance

AdaptHealth stock traded down $0.30 during trading hours on Friday, reaching $8.66. 1,608,048 shares of the company were exchanged, compared to its average volume of 1,212,907. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of -5.25, a PEG ratio of 1.08 and a beta of 1.44. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The stock has a 50-day moving average of $9.86 and a 200 day moving average of $10.07.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AHCO. Truist Financial lifted their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada lifted their price target on AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. UBS Group dropped their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Robert W. Baird raised their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Finally, Canaccord Genuity Group boosted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $13.80.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.